Vascarta
Summit, US · Founded 2020 · Delaware corporation
Founders & leadership
JF
Joel Friedman, MD, PhDChief Scientific Officer
RP
Richard Prince, PhDChairman, President, Chief Executive Officer
GS
Graeme SilbertChief Financial Officer, Chief Administration Officer
TG
Travis GeringNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$723.5K disclosed across 2 rounds · 2020–2022
▶$75KraisedMar 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶$75KraisedMar 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joel Friedman, MD, PhDExecutive Officer, Director
- Graeme SilbertExecutive Officer
- Travis GeringExecutive Officer, Director
- Richard Prince, PhDExecutive Officer, Director
- Amount sold
- $75K
- Minimum investment
- $25K
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$648.5KraisedApr 2021 · 13 investors · PharmaceuticalsRule 506(b)
▶$648.5KraisedApr 2021 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Travis GeringExecutive Officer, Director
- Joel Friedman, MD, PhDExecutive Officer, Director
- Richard Prince, PhDExecutive Officer, Director
- Graeme SilbertExecutive Officer
- Offering amount
- $1M
- Amount sold
- $648.5K
- Minimum investment
- $25K
- Proceeds to insiders
- $250K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Vascarta raised?
- Vascarta has disclosed $723.5K raised across 2 rounds.
- Where is Vascarta headquartered?
- Vascarta is headquartered in Summit, US.